Despite considerable advances in our understanding of the biology
that underlies tumor development and progression of cancer and the
rapidly evolving field of personalized medicine, cancer is still
one of the deadliest diseases. Many cancer patients have benefited
from the survival improvements observed with targeted therapies but
only a small subset of patients receiving targeted drugs experience
an objective response. Because cancer is a complex and
heterogeneous disease, the search for effective cancer treatments
will need to address not only patient-specific molecular defects
but also aspects of the tumor microenvironment. The functional
tumor profiling directly measures the cellular phenotype, in
particular tumor growth, in response to drugs using patient-derived
tumor models and might be the next step toward precision oncology.
In this Element, the authors discuss the personalized drug
screening as a novel patient stratification strategy for the
determination of individualized treatment choices in oncology.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!